Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Revenue

    Back to Income Statement
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹198 Cr₹154 Cr₹140 Cr₹114 Cr₹69 Cr

What is the latest Revenue of KILITCH DRUGS (INDIA) ?

The latest Revenue ratio of KILITCH DRUGS (INDIA) is ₹198 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹198 Cr
Mar2024₹154 Cr
Mar2023₹140 Cr
Mar2022₹114 Cr
Mar2021₹69 Cr

How is Revenue of KILITCH DRUGS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹198 Cr
28.47
Mar2024 ₹154 Cr
10.58
Mar2023 ₹140 Cr
22.20
Mar2022 ₹114 Cr
66.71
Mar2021 ₹69 Cr -

Compare Revenue of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹557.6 Cr -1.9% -9.7% 4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,628.0 Cr 3.5% 5.6% 11.9% Stock Analytics
DIVIS LABORATORIES ₹167,975.0 Cr -1.3% 4.5% 16.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,804.0 Cr -0.7% 6.9% 47.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,829.0 Cr 1.3% 5.1% 17.5% Stock Analytics
CIPLA ₹106,768.0 Cr -1.9% -0.3% -6% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-1.9%

-9.7%

4.9%

SENSEX

-4.1%

-5.8%

5.8%


You may also like the below Video Courses